Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Belinostat | 0.316 | 1.000 | uM | 72 | hr | 3 | 955 | 569 | 0.0886 | 0.1069 | 0.5958 | 0.5774 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1381 | 996 | 0.0890 | 0.0871 | 0.7212 | 0.7176 |
A-375 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 2192 | 327 | 0.0894 | 0.0857 | 0.1492 | 0.1490 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 2168 | 298 | 0.0896 | 0.0889 | 0.1375 | 0.1262 |
COLO 858 | Vemurafenib | I-BET151 | 0.316 | 1.000 | uM | 72 | hr | 3 | 1034 | 645 | 0.0899 | 0.1085 | 0.6238 | 0.5981 |
A-375 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 2204 | 325 | 0.0900 | 0.0825 | 0.1475 | 0.1694 |
MZ7-mel | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 536 | 86 | 0.0905 | 0.1047 | 0.1604 | 0.1707 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1827 | 89 | 0.0910 | 0.1035 | 0.0487 | 0.0423 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 2098 | 334 | 0.0923 | 0.0842 | 0.1592 | 0.1524 |
COLO 858 | Vemurafenib | Belinostat | 1.000 | 1.000 | uM | 72 | hr | 2 | 1194 | 791 | 0.0925 | 0.0829 | 0.6625 | 0.6809 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 2198 | 268 | 0.0925 | 0.0889 | 0.1219 | 0.1262 |
COLO 858 | Vemurafenib | I-BET | 1.000 | 1.000 | uM | 72 | hr | 2 | 1193 | 888 | 0.0932 | 0.0928 | 0.7443 | 0.7455 |
COLO 858 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 1 | 1468 | 1062 | 0.0932 | 0.0767 | 0.7234 | 0.7291 |
A-375 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 2292 | 344 | 0.0934 | 0.0857 | 0.1501 | 0.1490 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 3.160 | uM | 72 | hr | 1 | 1246 | 683 | 0.0934 | 0.0962 | 0.5482 | 0.5276 |
COLO 858 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 1 | 1635 | 1328 | 0.0939 | 0.0728 | 0.8122 | 0.8214 |
A-375 | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 2145 | 178 | 0.0943 | 0.1060 | 0.0830 | 0.0803 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 3.160 | uM | 72 | hr | 2 | 1207 | 631 | 0.0955 | 0.0962 | 0.5228 | 0.5276 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1514 | 710 | 0.0955 | 0.1083 | 0.4690 | 0.4526 |
A-375 | Vemurafenib | Belinostat | 0.100 | 1.000 | uM | 72 | hr | 1 | 1844 | 583 | 0.0963 | 0.0930 | 0.3162 | 0.3181 |
A-375 | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 1 | 1798 | 263 | 0.0966 | 0.0897 | 0.1463 | 0.1612 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 1 | 1460 | 1042 | 0.0966 | 0.0871 | 0.7137 | 0.7176 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 475 | 178 | 0.0969 | 0.1000 | 0.3747 | 0.3467 |
A-375 | Vemurafenib | Belinostat | 0.100 | 1.000 | uM | 72 | hr | 2 | 1843 | 570 | 0.0972 | 0.0930 | 0.3093 | 0.3181 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1185 | 610 | 0.0974 | 0.1170 | 0.5148 | 0.4614 |